Upload File

The top documents of office-of-health-economics

Towse ISPOR Incoming President's Remarks
Towse ISPOR Incoming President's Remarks
1.598 views
Adaptive Pathways as Incentives for Innovation
Adaptive Pathways as Incentives for Innovation
651 views
Adrian Towse Presentation - Affordability
Adrian Towse Presentation - Affordability
612 views
ISPOR poster ri lwcp 140515
ISPOR poster ri lwcp 140515
648 views
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
Adrian Towse Presentation - Modelling value of early access, 19 May 2015
589 views
Devlin mcda philadelphia ispor 150515
Devlin mcda philadelphia ispor 150515
511 views
ISPOR poster - direct elicitation 280415
ISPOR poster - direct elicitation 280415
639 views
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries
HATi Toyko 2016 - Building Efficient Healthcare Systems Through Integrated Health Care Decision Making in Low and Middle Income Countries
234 views
Equity Adjusted QALYs? QALYs and Equity
Equity Adjusted QALYs? QALYs and Equity
869 views
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
757 views
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
HEALTH ECONOMIC EVALUATION OF BIBLIOMETRIC TRENDS IN SUB-SAHARAN AFRICA
315 views
Availability, accessibility and applicability of evidence: Transferability - Data versus pragmatism
Availability, accessibility and applicability of evidence: Transferability - Data versus pragmatism
602 views
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
340 views
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potential for PBRSAs
How can HTA’s in Asia respond to Increased Clinical Uncertainty: the potential for PBRSAs
589 views
The economics of medical research: Public/private spillovers and the rate of return
The economics of medical research: Public/private spillovers and the rate of return
195 views
Does society wish to prioritise end-of-life treatments over other types of treatment?
Does society wish to prioritise end-of-life treatments over other types of treatment?
406 views
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
“Multi-indication Pricing: Do we want it? Can we operationalize it?”
544 views
Multi-Indication Pricing: Do we want it? Can we operationalize it?
Multi-Indication Pricing: Do we want it? Can we operationalize it?
559 views
Can we really compare and aggregate PRO data between people and setting?
Can we really compare and aggregate PRO data between people and setting?
148 views
Is balancing value demonstration for payers and patient interests a feasible notion? A Health System Perspective
Is balancing value demonstration for payers and patient interests a feasible notion? A Health System Perspective
458 views